Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPIAP46 is a pseudogene related to the peptidylprolyl isomerase A (PPIA, cyclophilin A) gene family. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations or lack of regulatory elements that prevent protein expression[3][9]. While some pseudogenes can participate in regulating gene expression (for example, by acting as microRNA decoys or being transcribed into non-coding RNA with potential regulatory functions), there is no direct evidence that PPIAP46 plays such roles. Importantly, PPIAP46 does not code for an active enzyme or receptor and is not considered a molecular target for drugs or therapeutic intervention. If information about biological function, disease relevance, or interactions is needed for "peptidylprolyl isomerase A" (PPIA, cyclophilin A), consult the literature on PPIA, not pseudogenes like PPIAP46[3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 46 (PPIAP46).